News

Published on 8 Aug 2022 on Simply Wall St. via Yahoo Finance

Lipocine Inc. (NASDAQ:LPCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market...


Article preview image

Lipocine (NASDAQ:LPCN) has had a rough week with its share price down 7.1%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Particularly, we will be paying attention to Lipocine's ROE today.

Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.

See our latest analysis for Lipocine

NASDAQ.LPCN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is Lipocine Inc.'s (NASDAQ:LPCN) Stock's Recent Performance Being Led By Its Attractive Financial...

Lipocine (NASDAQ:LPCN) has had a great run on the share market with its stock up by a significant...

Simply Wall St. via Yahoo Finance 16 Jan 2023

Lipocine To Focus On Central Nervous System Conditions; Explores Partnerships For Non-Core Assets

Lipocine Inc (NASDAQ: LPCN) announced its plans to focus on treating Central Nervous System (CNS)...

Benzinga via Yahoo Finance 26 Sep 2022

Lipocine Inc. (NASDAQ:LPCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market...

Lipocine (NASDAQ:LPCN) has had a rough week with its share price down 7.1%. But if you pay close ...

Simply Wall St. via Yahoo Finance 8 Aug 2022

Lipocine Posts Encouraging Data For Testosterone Prodrug In NASH Patients

Lipocine Inc (NASDAQ: LPCN) has announced topline results from its Open-Label Extension (OLE) stu...

Benzinga via Yahoo Finance 13 May 2022

Shareholders in Lipocine (NASDAQ:LPCN) are in the red if they invested five years ago

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. ...

Simply Wall St. via Yahoo Finance 4 May 2022

53 Biggest Movers From Yesterday

 

Benzinga 30 Mar 2022

36 Stocks Moving In Tuesday's Mid-Day Session

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday...

Benzinga 29 Mar 2022

20 Stocks Moving in Tuesday's Pre-Market Session

Don’t forget to check out our premarket coverage here .

Benzinga 29 Mar 2022

Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates

The Food and Drug Administration approval calendar was light in February. Nevertheless, the month...

Benzinga 2 Mar 2022

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine...

Here's a roundup of top developments in the biotech space over the last 24 hours: Illumina, Inc. ...

Benzinga 6 Jan 2022